Results 81 to 90 of about 4,554 (207)

Analysis of key clinical features for achieving complete remission in stage III and IV non-small cell lung cancer patients

open access: yesRespiratory Research, 2019
Background Although development of immune checkpoint inhibitors and various molecular target agents has extended overall survival time (OS) in advanced non-small cell lung cancer (NSCLC), a complete cure remains rare.
Takuya Aoki   +23 more
doaj   +1 more source

Evolving strategies in prostate cancer: Emerging approaches and unmet needs from the Bridging the Gaps in Prostate Cancer expert panel

open access: yesCancer, Volume 132, Issue 4, 15 February 2026.
Abstract Background The expansion of treatment options for prostate cancer (PC) has improved disease‐specific and overall survival outcomes but has also raised questions about the optimal level of treatment needed for patients based on their individual prognosis and accounting for potential toxicity, incorporating quality of life considerations ...
Rana R. McKay   +18 more
wiley   +1 more source

Dataset related to article "Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification?"

open access: yes, 2020
This record contains raw data related to article “Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification?" Background and purpose ...
franceschini, davide   +13 more
core   +1 more source

Pediatric nasopharyngeal cancer with repeated oligometastases involving the bone, liver and distant lymph nodes who achieved cure after radiotherapy [PDF]

open access: yes
Systemic chemotherapy is a standard treatment for Stage IVc nasopharyngeal carcinoma (NPC). Stage IVc NPC patients with oligometastases have a better prognosis, and local therapy has an important role in further development of the disease.
Suzuki, Hideaki   +8 more
core   +2 more sources

Stereotactic body radiotherapy improves the survival of patients with oligometastatic non‐small cell lung cancer

open access: yesCancer Medicine, 2019
Purpose The aim of the study was to evaluate the efficacy and safety of stereotactic body radiotherapy (SBRT) for pulmonary lesions in oligometastatic non‐small cell lung cancer (NSCLC) patients, to explore prognostic factors of progression‐free survival
Wen Ouyang   +7 more
doaj   +1 more source

Bone Metastasis: Molecular Mechanisms, Clinical Management, and Therapeutic Targets

open access: yesMedComm, Volume 7, Issue 2, February 2026.
This figure emphasizes current understanding of the regulatory networks, approach of diagnose, available preclinical models and clinical management of bone metastasis. to guide future therapeutic development. A deep understanding of these aspects enables the prevention of bone metastasis and the implementation of effective therapeutic strategies ...
Jingyuan Wen   +5 more
wiley   +1 more source

PSMA PET‐directed radiotherapy for prostate cancer: From precision planning to future innovations

open access: yesVIEW, Volume 7, Issue 1, February 2026.
Prostate‐specific membrane antigen (PSMA) positron emission tomography (PET) imaging enables highly sensitive detection of prostate cancer recurrence and precise lesion mapping. This review summarizes current evidence and emerging applications of PSMA PET in radiotherapy, including diagnostic staging, target delineation, adaptive planning, and outcome ...
Wenpeng Huang   +7 more
wiley   +1 more source

Stereotactic Body Radiotherapy and Immunotherapy for Older Patients with Oligometastases: A Proposed Paradigm by the International Geriatric Radiotherapy Group

open access: yes, 2022
The standard of care for metastatic disease is systemic therapy. A unique subset of patients with limited metastatic disease defined as distant involvement of five anatomic sites or less (oligometastases) have a better chance of remission or improved ...
Alexander Chi   +16 more
core   +1 more source

Clinical experience with a same‐day simulation and treatment program for stereotactic radiation therapy on a C‐arm linac

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 1, January 2026.
Abstract Purpose We report our experience with the implementation of a same‐day simulation and treatment C‐arm linear accelerator (linac)‐based stereotactic program for patients with intracranial and extracranial metastatic disease. Methods Between May 2021 and October 2023, patients were treated in our same‐day program with linac‐based SRS/SBRT.
Michalis Aristophanous   +12 more
wiley   +1 more source

Oligometastases [PDF]

open access: yesJournal of Thoracic Oncology, 2018
Joachim Widder, Joyce Lodeweges
openaire   +2 more sources

Home - About - Disclaimer - Privacy